BLife Therapeutics is a subsidiary of BetterLife Pharma, an emerging
biotech company developing and refining drug candidates from a broad
set of complementary Interferon-based technologies which have the potential
to engage the immune system to fight virus infections and/or to directly inhibit
tumours to treat specific types of cancer.